Drug
Dexpramipexole Dihydrochloride
Dexpramipexole Dihydrochloride is a pharmaceutical drug with 5 clinical trials. Currently 2 active trials ongoing.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Completion Rate
0%(0/3)
Active Trials
2(40%)
Terminated
3(60%)
Phase Distribution
Ph phase_2
1
20%
Ph phase_3
4
80%
Phase Distribution
0
Early Stage
1
Mid Stage
4
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
4(80.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 3 finished
Non-Completion Rate
100.0%
3 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Terminated(3)
Detailed Status
Terminated3
Active, not recruiting2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
0.0%
Most Advanced
Phase 3
Trials by Phase
Phase 21 (20.0%)
Phase 34 (80.0%)
Trials by Status
active_not_recruiting240%
terminated360%
Recent Activity
2 active trials
Showing 5 of 5
terminatedphase_3
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.
NCT05763121
terminatedphase_3
Phase III Long-Term Extension Study With Dexpramipexole
NCT06388889
terminatedphase_3
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)
NCT05813288
active_not_recruitingphase_3
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma
NCT05748600
active_not_recruitingphase_2
A Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPD
NCT06533553
Clinical Trials (5)
Showing 5 of 5 trials
NCT05763121Phase 3
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.
NCT06388889Phase 3
Phase III Long-Term Extension Study With Dexpramipexole
NCT05813288Phase 3
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)
NCT05748600Phase 3
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma
NCT06533553Phase 2
A Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPD
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5